Ozempic and Life Insurance: Could Weight-Loss Drugs Lower Your Rate?

QUICK ANSWER

If you take Ozempic, Wegovy, Mounjaro, or another GLP-1 weight-loss drug, you can still get life insurance, and the newest data suggests it may help your rate rather than hurt it. In February 2026 the German reinsurer Munich Re published findings from 41 million insured lives showing that GLP-1 users had lower all-cause mortality than non-users, in both diabetic and non-diabetic groups. Most well-managed applicants on a GLP-1 land somewhere between Standard Plus and a mild table rating (a pricing tier above Standard), depending on how long they have been on the drug and what their labs look like. The catch is that carriers read this new science very differently from one another, so the company you apply with matters more than the medication itself.

You started a weight-loss shot to get healthier, and now you are wondering if it just became a black mark on your life insurance application. That is a fair worry, and for years the honest answer was murky.

Here is what changed. The data is in, and it is pointing the other way. Carriers are starting to treat sustained GLP-1 use the way they eventually treated cholesterol medication, as a sign you are managing your health instead of ignoring it.

You are not uninsurable for taking Ozempic, and you may not even be rated for it. You just need to apply with a company that has caught up to the science, and you need your file to tell the right story.

What GLP-1 (Ozempic or others) Weight-Loss Drugs Actually Mean for Life Insurance Underwriting

When an underwriter sees a GLP-1 prescription, the drug itself is not the headline. They are reading two things at once. First, why are you on it, since semaglutide and tirzepatide are prescribed for type 2 diabetes, obesity, and increasingly for cardiovascular risk, and the underlying reason carries its own rating. Second, is it working, which they judge from your weight trend, your A1C, your blood pressure, and your lipid panel over time.

This is where the Munich Re report matters. Their analysis of 41 million insured lives, covering 2015 through January 2025, found that GLP-1 users showed lower all-cause mortality than non-users. Separate clinical data they cited showed semaglutide produced a roughly 20% reduction in major cardiovascular events and a 19% improvement in all-cause mortality, and some real-world groups saw mortality risk drop by as much as 43%. Munich Re projected that obesity-drug effects could account for 0.2% to 0.5% of annual mortality improvement across the population over the next two decades.

Translation for your application: a documented, steady weight-loss trend with improving labs is exactly the kind of evidence that can move you toward better rate classes. Carriers that specialize in metabolic and impaired-risk underwriting are the ones most likely to credit it. The variable you control is the record. An underwriter cannot reward progress they cannot see, so recent labs and a clear medication history do real work here.

THE MAINTENANCE-RECORDS RULE

Think about two used trucks with the same mileage. One comes with a folder of oil-change and service records, and the other comes with nothing. The mechanic appraises the documented one higher every time, because the records prove it was cared for. A GLP-1 prescription plus a year of improving labs is your service folder, and the right underwriter prices you up for having it.

What Rate Class Can You Expect on a GLP-1? (The Ratings Ladder)

Big Lou sorts every applicant onto a 12-rung Ratings Ladder, from the best preferred pricing down through the table ratings, which are approvals priced in steps above Standard. A table rating is not a rejection, it is a yes at a higher price, and each step up adds roughly 25% to the base rate. Here is roughly where weight-loss-drug users tend to land, assuming no major unrelated conditions.

Your GLP-1 Profile	Typical Rate Class	What That Means
On a GLP-1 for 12+ months, weight down and holding, A1C and blood pressure controlled, no other major flags	Standard Plus to Standard	Same pricing as a typical healthy applicant your age, or close to it
On a GLP-1 for 6 to 12 months, weight dropping and labs improving, but a short track record	Standard to Table 2	Standard pricing, or a mild table rating a step or two above it
Newly started (under 6 months), weight still high, or stopped and restarted more than once	Table 2 to Table 4	Approved above Standard while the underwriter waits for a track record
Higher BMI with inconsistent GLP-1 use, plus other conditions like sleep apnea or type 2 diabetes	Table 4 to Table 6	Approved, priced meaningfully higher, and worth shopping carefully

These are general landing zones, not quotes, and your actual class depends on your full health picture and the carrier reading it.

On a Weight-Loss Drug vs. Denied: Understanding the Difference

A table rating and a denial are not the same thing, and people mix them up all the time. A table rating means a carrier said yes and priced your policy a few steps above Standard. A denial means one carrier said no, usually because of how their specific underwriting manual reads one piece of your file.

A denial from one company is not a verdict on you. Impaired-risk specialists shop multiple carriers whose manuals favor different health profiles, and on a fast-moving topic like GLP-1 drugs those manuals are all over the map right now. One carrier may still treat a weight-loss prescription as an open question, while another already credits it as proactive care. Same applicant, very different answer, which is the whole reason to apply through someone who knows which door to knock on.

How to Get the Best Rate While Taking a Weight-Loss Drug

1. Build a track record before you apply if you can. Adherence is the soft spot in this whole story, since industry data shows discontinuation reaching about 48% at 12 months and 70% at 24 months. Six to twelve months of steady, documented use does more for your rate than almost anything else.

2. Get your labs recent and on file. A current A1C, lipid panel, and blood pressure reading that show the drug working are the evidence an underwriter needs. Old or missing labs force them to assume the worst.

3. Know your numbers and your reason. Be ready to state why you were prescribed the medication, your starting and current weight, and your latest labs. Clarity speeds the file and prevents guesswork.

4. Ask for a rate class review if you have been on the drug a while. If you were rated or quoted high before your progress showed up, your improved labs may support a better class now.

5. Apply through a broker who knows the metabolic manuals. The carrier that credits GLP-1 use is not always the one with the loudest ad, and matching your file to the right underwriter is the difference between Standard and a needless table rating.

   
   

What To Do Next

If you have been quoted high before, or turned down somewhere, that experience is doing a number on your expectations. It probably happened before the data caught up, or with a carrier that was never the right fit for your situation in the first place.

You do not have to figure out which company reads GLP-1 use the right way. That is the part we handle, and it costs you nothing to find out where you actually land.

READY TO FIND YOUR RATE?

A 10-minute call is all it takes to find out where you actually land on the Ratings Ladder, and which carriers are most likely to put you there. No cost, no obligation. Call 888-893-2105 or click Get Quote and we will do the shopping for you.

Frequently Asked Questions

Can I get life insurance if I take Ozempic or another GLP-1 drug?

Yes, taking a GLP-1 weight-loss drug does not block you from coverage. Carriers look at why you are on it and how well it is working, and a documented, steady weight-loss trend often helps your case. Most well-managed applicants land between Standard Plus and a mild table rating.

What rate class do people on weight-loss drugs usually get?

It varies with how long you have been on the medication and what your labs show. Applicants with 12 or more months of steady use and controlled numbers often reach Standard or Standard Plus, while newer users may see a temporary table rating until a track record builds.

Does taking Ozempic automatically disqualify me from life insurance?

No, it does not. The medication on its own is not a disqualifier, and the newest mortality data has carriers increasingly viewing sustained use as a sign of proactive health management, similar to how they came to view cholesterol medication.

How does a weight-loss drug affect my premium?

It can push your premium either direction depending on the carrier and your file. Strong, documented progress can support a better class and a lower premium, while the underlying condition or a very short track record can add a table rating that raises it. Carrier selection drives a lot of the spread.

What is the difference between a table rating and a denial?

A table rating is an approval priced in steps above Standard, with each step adding roughly 25% to the base rate. A denial is a single carrier declining to offer coverage, usually because of one manual reading one part of your file, and it can often be beaten by applying with a different carrier.

Does every insurance company rate GLP-1 use the same way?

No, and that is the most important point. GLP-1 underwriting is evolving fast, so one carrier may treat a weight-loss prescription as an open question while another already credits it as managed care. The same applicant can get very different offers, which is why shopping multiple carriers matters.

What should I do if I was already denied for life insurance?

Do not treat one denial as the final word. An impaired-risk specialist can identify carriers whose manuals favor your profile and reapply on your behalf, and if you have been on a GLP-1 long enough to show progress, your improved labs may now support an approval and a better class.

Will stopping my weight-loss drug get me a better rate?

Usually not, and it can backfire. Underwriters reward sustained results and documented adherence, so a stable history on the medication generally reads better than a recent stop. Talk to your doctor about treatment decisions, and let the underwriting follow your health, not the other way around.